Back to search

Institutional Repository of Vilnius University

Bakterinių amidohidrolazių pritaikymo vėžio terapijoje tyrimas in vitro /

Abstract

dc:description

Despite major progress in cancer therapy developement in recent years, cancer ranks as one of the leading causes of death globally. Conventional chemotherapy drugs used in cancer therapy often lack selectivity and cause side effects to normal rapidly proliferating cells. One of the most promising new therapeutic strategies is suicide gene therapy also known as gene-directed enzyme prodrug therapy, GDEPT. Although, in past decades such enzyme/prodrug systems as cytosine deaminase/5-fluorocytosine and herpes simplex virus thymidine kinase/ganciclovir reached significant results in preclinical and clinical trials, studies are further continued to ensure safety and efficiency of such therapy, since the U.S. Food and Drug Administration (FDA) hasn't yet approved these systems for widespread use. The aim of this study was to investigate bacterial amidohydrolases D8_RL and YqfB discovered from metagenomic libraries in Vilnius University Biochemistry Institute Molecular microbiology and biotechnology departement as prodrug activating enzymes for the application in cancer suicide gene therapy. To achieve this, first, most potential prodrugs, various cytidines modified at the N4 position, were shown to be non-cytotoxic or only slightly cytotoxic to HCT116 and MCF-7 cell lines. After transduction, the expression of these amidohydrolase genes was demonstrated by quantitative PCR, however, only the YqfB enzyme in the HCT116 cell line was detected by Western blot. Nevertheless, a decrease in the viability of HCT116 cells (but not MCF-7) transduced with both of the investigated amidohydrolase genes was observed after exposure of five of seven prodrugs at the 10 µM concentration compared to the empty vector-transduced cell line. The results obtained in this study suggest that the bacterial amidohydrolases D8_RL and YqfB may be a potential tool to be used in further studies for the application in cancer therapy.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zubavičiūtė, Simona,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Zubavičiūtė, Simona,. Bakterinių amidohidrolazių pritaikymo vėžio terapijoje tyrimas in vitro /. Institutional Repository of Vilnius University, 2022. https://repository.vu.lt/VU:ELABAETD192979173&prefLang=en_US